Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients

被引：0
|
作者：
Kuroda, Akio
Tsuruo, Miho
Takeshi, Kondo
Aki, Nanako
Oguro, Yukari
Endo, Itsuro
Aihara, Ken-ichi
Tamaki, Motoyuki
Matsumoto, Toshio
Matsuhisa, Munehide
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
906-P
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [1] Type 2 Diabetes: Direct Comparison between Insulin Glargine and Insulin Degludec Comment
    Ritzel, Robert
    DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (06) : 546 - 546
  • [2] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [3] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Yoshiki Kusunoki
    Tomoyuki Katsuno
    Kana Miyakoshi
    Takashi Ikawa
    Rie Nakae
    Fumihiro Ochi
    Masaru Tokuda
    Takafumi Akagami
    Kazuki Murai
    Masayuki Miuchi
    Tomoya Hamaguchi
    Jun-ichiro Miyagawa
    Mitsuyoshi Namba
    Diabetes Therapy, 2013, 4 : 461 - 472
  • [4] Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
    Jammah, Anwar Ali
    PRIMARY CARE DIABETES, 2021, 15 (01) : 132 - 137
  • [5] Insulin Degludec Provides Similar Glycemic Control with Insulin Glargine in Patients with Type 2 Diabetes
    Yamada, Satoru
    Komuro, Manaho
    Inoue, Gaku
    Tabata, Mitsuhisa
    Matsubara, Hajime
    Irie, Junichiro
    DIABETES, 2016, 65 : A250 - A251
  • [6] Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
    Home, P. D.
    Meneghini, L.
    Wendisch, U.
    Ratner, R. E.
    Johansen, T.
    Christensen, T. E.
    Jendle, J.
    Roberts, A. P.
    Birkeland, K. I.
    DIABETIC MEDICINE, 2012, 29 (06) : 716 - 720
  • [7] A comparison of quality of life measured with the SF-36 for insulin degludec and insulin glargine in people with type 1 diabetes
    Home, P. D.
    Meneghini, L.
    Ratner, R. E.
    Johansen, T.
    Christensen, T. E.
    Jendle, J.
    Roberts, A. P.
    DeVries, J. H.
    Birkeland, K. I.
    DIABETOLOGIA, 2011, 54 : S384 - S384
  • [8] IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES
    Visentin, R.
    Schiavon, M.
    Giegerich, C.
    Sieber, J.
    Man, C. Dalla
    Cobelli, C.
    Klabunde, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A18 - A18
  • [9] COMPARISON OF INSULIN DEGLUDEC AND GLARGINE U100 IN PATIENTS WITH TYPE 1 DIABETES PRONE TO SEVERE NOCTURNAL HYPOGLYCAEMIA
    Agesen, R.
    Alibegovic, A.
    Andersen, H.
    Beck-Nielsen, H.
    Gustenhoff, P.
    Hansen, T.
    Hedetoft, C.
    Jensen, T.
    Juhl, C.
    Kryger, A.
    Lerche, S.
    Norgaard, K.
    Parving, H. -H.
    Sorensen, A.
    Tarnow, L.
    Thorsteinsson, B.
    Pedersen-Bjergaard, U.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A93 - A94
  • [10] Efficacy and safety of switching from insulin glargine to insulin degludec in young people with type 1 diabetes
    Urakami, Tatsuhiko
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2016, 63 (02) : 159 - 167
12345